Research programme: anti-inflammatory therapeutics - Modern Biosciences

Drug Profile

Research programme: anti-inflammatory therapeutics - Modern Biosciences

Latest Information Update: 29 Jun 2015

Price : $50

At a glance

  • Originator University of Aberdeen
  • Class Small molecules
  • Mechanism of Action Tumour necrosis factor inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Rheumatoid arthritis
  • No development reported Inflammation; Osteoporosis

Most Recent Events

  • 29 Jun 2015 Preclinical trials in Rheumatoid arthritis in United Kingdom (PO)
  • 07 Mar 2011 No development reported - Preclinical for Inflammation in United Kingdom (PO)
  • 07 Mar 2011 No development reported - Preclinical for Osteoporosis in United Kingdom (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top